| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| vaccin contre la diphtérie, la coqueluche, le tétanos et Haemophilus influenzae de type B |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Hib Haemophilus influenzae de type b non spécifié |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| vaccin contre Haemophilus influenzae de type B (Hib), la diphtérie, le tétanos et la coqueluche, flacon et seringue préremplie |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| vaccin contre Haemophilus Influenzae de type B (Hib), la diphtérie, le tétanos et la coqueluche, seringue préremplie |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| vaccin contre Haemophilus influenzae de type B (Hib), la diphtérie, le tétanos et la coqueluche, flacon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| vaccin injectable (poudre pour reconstitution) et diluant contre Haemophilus influenzae de type B |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| vaccin contre la diphtérie, la coqueluche, le tétanos, la polio et Haemophilus influenzae de type b |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| vaccin contre la diphtérie, le tétanos, la coqueluche, la poliomyélite et contre Haemophilus influenzae type b, fiole de 0,5 mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| vaccin conjugué à un polysaccharide contre Haemophilus influenzae de type b (anatoxine dipthérique conjuguée) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| vaccin oligosacharidique conjugué contre Haemophilus influenzae de type b (protéine conjuguée dipthérique CRM>197<) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Diphtheria and tetanus toxoi + haemophilus b conjugate vacc 0.6ml/0.5ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Diphtheria and tetanus toxoi + haemophilus b conjugate vacc 7.5ml/5ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| 10 microgrammes de polysaccharides contre l'Haemophilus influenzae et 24 microgrammes d'anatoxine tétanique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| anatoxines diphtérique et tétanique, flacon de 0,5 mL et vaccin conjugué contre Haemophilus influenzae de type b, flacon d'une suspension injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Administration of first dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Administration of second dose of Haemophilus influenzae type b vaccine |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Administration of third dose of Haemophilus influenzae type b vaccine |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Administration of booster dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| intoxication par un vaccin contre Haemophilus influenzae de type B |
Causative agent (attribute) |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| intoxication accidentelle par un vaccin contre Haemophilus influenzae de type B |
Causative agent (attribute) |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| intoxication intentionnelle par un vaccin contre Haemophilus influenzae de type B |
Causative agent (attribute) |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| intoxication d'intention indéterminée par un vaccin contre Haemophilus influenzae de type B |
Causative agent (attribute) |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Adverse reaction to Haemophilus influenzae type b vaccine |
Causative agent (attribute) |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to Haemophilus influenzae type b vaccine |
Causative agent (attribute) |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Administration of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| vaccin contre Haemophilus influenzae de type b et le méningocoque de groupe C |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Hib-HB Haemophilus influenzae de type B + hépatite B pédiatrique non spécifié |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| flacon de 0,5 mL d'une solution injectable de 7,5 microgrammes contre l'Haemophilus influenza de type B, de 5 microgrammes de l'antigène de surface du virus de l'hépatite B recombinant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| vaccin contre Haemophilus influenzae de type B et contre le tétanos |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| flacon et diluant contenant une poudre pour solution injectable polysaccharidique de 10 microgrammes contre l'Haemophilus influenzae b, 30 microgrammes d'anatoxine tétanique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche acellulaire 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| vaccin contre la diphtérie, le tétanos, la coqueluche, la poliomyélite, l'hépatite B (recombinant) et Haemophilus influenzae de type B (recombinant) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Administration of fourth dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Administration of first dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Administration of second dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Administration of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Administration of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Administration of Haemophilus influenzae type b and meningitis C vaccine |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| vaccin contre la diphtérie, le tétanos et Haemophilus influenzae de type B |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Administration of Haemophilus influenzae type b and meningitis C vaccine |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Administration of fourth dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Administration of first dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Administration of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Administration of second dose of Haemophilus influenzae type b vaccine |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Administration of second dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Administration of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Administration of first dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Administration of third dose of Haemophilus influenzae type b vaccine |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Administration of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Administration of booster dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Administration of second dose of Haemophilus influenzae type b vaccine |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Administration of first dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Administration of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Administration of third dose of Haemophilus influenzae type b vaccine |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Administration of booster dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to Haemophilus influenzae type b vaccine |
Causative agent (attribute) |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine/Hepatitis B Surface Antigen Vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Administration of second dose of Haemophilus influenzae type b and meningitis C vaccine |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
| Administration of first dose of vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens (procedure) |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
| Haemophilus b polysaccharide 10micrograms/tetanus toxoid 30micrograms powder for conventional release solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
5 |
| Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Administration of first dose of diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and tetanus vaccine |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| flacon de 0,5 mL d'une solution injectable de 7,5 microgrammes contre l'Haemophilus influenza de type B, de 5 microgrammes de l'antigène de surface du virus de l'hépatite B recombinant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Haemophilus b polysaccharide 10micrograms/tetanus toxoid 30micrograms powder for conventional release solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Vaccination for diphtheria, pertussis, tetanus, poliomyelitis, Hepatitis B virus and Haemophilus influenzae type b |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Hib 10 microg, anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b antigens (procedure) |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| anatoxine diphtérique 30 UI, anatoxine tétanique 40 UI, coqueluche acellulaire 25microg, antigène de surface du virus de l'hépatite B recombinant 10microg, poliomyélite inactivé, seringue préremplie de 0.5mL d'une solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Administration of vaccine product containing only Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
Direct substance |
False |
vaccin contre Haemophilus influenzae de type B |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]